2
|
Petyunina OV, Kopytsya MP, Berezin AE. The Utility of New Biomarker-based Predictive Model for Clinical Outcomes Among ST-elevation Myocardial Infarction Patients. THE OPEN BIOMARKERS JOURNAL 2020; 10:23-37. [DOI: 10.2174/1875318302010010023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/09/2020] [Revised: 03/06/2020] [Accepted: 04/03/2020] [Indexed: 05/15/2024]
Abstract
Aim:
To determine the discriminative potency of score to prognosticate poor clinical outcomes in ST-Segment Elevation Myocardial Infarction (STEMI) patients.
Methods:
From the entire population of STEMI (n=268), we enrolled 177 individuals with acute STEMI who underwent complete revascularization with primary Percutaneous Coronary Intervention (PCI). Clinical assessment, echocardiography, Doppler, and biomarkers’ measure were performed at baseline.
Results:
Combined endpoint (Major Cardiovascular Events - MACEs [composite of cardiovascular death, recurrent myocardial infarction, newly diagnosed Heart Failure] and hospitalization) was determined in 75 patients with acute STEMI population (40.6%). Newly onset heart failure (HF) was reported in 46 patients (26.0%), Cardiovascular (CV) death occurred in 12 patients (6.8%), MACEs were determined in 58 patients (32.8%), and recurrent hospitalization due to CV reasons was found in 17 (9.6%). The conventional risk predictive models were engineered by a combination of TIMI risk score +acute HF Killip class ≥ II + the levels of NT-pro brain natriuretic peptide > 300 pg / mL and troponin >0.05 ng/mL. We developed a new predictive model based on the presentation of T786С genotype of endothelial NO syntase gene (rs 2070744), А1166С in angiotensin-ІІ receptor-1 gene (rs5186) and serum levels of soluble suppressor tumorigenicity ≥35 pg/mL, vascular endothelial growth factor ≤172 pg/mL and macrophage inhibitory factor ≥2792.7 pg/mL. STEMI patients who had >5 score points demonstrated significantly worse prognosis than those who had ≤5 score points.
Conclusion:
Here we have reported that a new original predictive model is better than a conventional model in discriminative ability to predict combined clinical outcome in STEMI patients.
Collapse
|
3
|
García-Martín E, Navarro-Muñoz S, Rodriguez C, Serrador M, Alonso-Navarro H, Calleja M, Turpín-Fenoll L, Recio-Bermejo M, García-Ruiz R, Millán-Pascual J, Navacerrada F, Plaza-Nieto JF, García-Albea E, Agúndez JAG, Jiménez-Jiménez FJ. Association between endothelial nitric oxide synthase (NOS3) rs2070744 and the risk for migraine. THE PHARMACOGENOMICS JOURNAL 2019; 20:426-432. [PMID: 31792366 DOI: 10.1038/s41397-019-0133-x] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/20/2019] [Revised: 11/13/2019] [Accepted: 11/21/2019] [Indexed: 12/15/2022]
Abstract
Because nitric oxide could play an important role in the pathogenesis of migraine (suggested by experimental, neuropathological, biochemical, and pharmacological data), and a recent meta-analysis showed an association between the single-nucleotide polymorphism (SNP) rs2070744 in the endothelial nitric oxide synthase (eNOS or NOS3) gene (chromosome 7q36.1) and the risk for migraine in Caucasians, we attempted to replicate the possible association between this SNP and the and the risk for migraine in the Caucasian Spanish population. The frequencies for the NOS3 rs2070744 genotypes and allelic variants were assessed in 283 migraine patients and 287 healthy controls with a TaqMan-based qPCR Assay. The putative influence on genotype frequency of age at onset of migraine attacks, gender, family history of migraine, absence or presence of aura, and triggering of migraine attacks by ethanol, were also analyzed. The frequencies of NOS3 rs2070744 genotypes and allelic variants were not associated with the risk for migraine (OR [95%] CI for the minor allele = 0.91 [0.72-1.15]) and were not influenced by age at onset of migraine, gender, presence of aura, or triggering of migraine attacks by ethanol. NOS3 rs2070744CC genotypes were significantly more frequent in patients with a family history of migraine. NOS3 rs2070744 SNP is not associated with the risk for migraine in Caucasian Spanish people although it might be related to family history.
Collapse
Affiliation(s)
- Elena García-Martín
- University Institute of Molecular Pathology Biomarkers, UNEx, ARADyAL, Cáceres, Spain
| | - Santiago Navarro-Muñoz
- Section of Neurology, Hospital La Mancha-Centro, Alcázar de San Juan, Ciudad Real, Spain
| | - Christopher Rodriguez
- University Institute of Molecular Pathology Biomarkers, UNEx, ARADyAL, Cáceres, Spain
| | - Mercedes Serrador
- Department of Family Medicine, Hospital "Príncipe de Asturias", Universidad de Alcalá, Alcalá de Henares, Madrid, Spain
| | | | - Marisol Calleja
- Section of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain
| | - Laura Turpín-Fenoll
- Section of Neurology, Hospital La Mancha-Centro, Alcázar de San Juan, Ciudad Real, Spain
| | - Marta Recio-Bermejo
- Section of Neurology, Hospital La Mancha-Centro, Alcázar de San Juan, Ciudad Real, Spain
| | - Rafael García-Ruiz
- Section of Neurology, Hospital La Mancha-Centro, Alcázar de San Juan, Ciudad Real, Spain
| | - Jorge Millán-Pascual
- Section of Neurology, Hospital La Mancha-Centro, Alcázar de San Juan, Ciudad Real, Spain
| | - Francisco Navacerrada
- Section of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain
| | | | - Esteban García-Albea
- Department of Medicine-Neurology, Hospital "Príncipe de Asturias", Universidad de Alcalá, Alcalá de Henares, Madrid, Spain
| | - José A G Agúndez
- University Institute of Molecular Pathology Biomarkers, UNEx, ARADyAL, Cáceres, Spain
| | | |
Collapse
|
4
|
Kukava NG, Titov BV, Osmak GJ, Matveeva NA, Kulakova OG, Favorov AV, Shakhnovich RM, Ruda MY, Favorova OO. Multilocus Analysis of Genetic Susceptibility to Myocardial Infarction in Russians: Replication Study. Acta Naturae 2017; 9:74-83. [PMID: 29340220 PMCID: PMC5762831] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2017] [Indexed: 11/25/2022] Open
Abstract
In search of genetic markers of myocardial infarction (MI) risk, which have prognostic significance for Russians, we performed a replication study of MI association with genetic variants of PCSK9 (rs562556), APOE (epsilon polymorphism, rs7412 and rs429358), LPL (rs320), MTHFR (rs1801133), eNOS (rs2070744), and the 9p21 region (rs1333049) in 405 patients with MI and 198 controls. Significant MI association was observed with variants of the lipid metabolism genes (PCSK9, APOE and LPL), and of eNOS. The SNPs in the MTHFR gene and the 9p21 region were not significantly associated with MI one by one but were included in several different MI-associated allelic combinations identified by multilocus analysis. Since we have not revealed nonlinear epistatic interactions between the components of the identified combinations, we postulate that the cumulative effect of genes that form a combination arises from the summation of their small independent contributions. The prognostic significance of the additive composite model built from the PCSK9, APOE, LPL, and eNOS genes as genetic markers was assessed using ROC analysis. After we included these markers in the previously published composite model of individual genetic risk of MI, the prognostic efficacy in our sample reached AUC = 0.676. However, the results obtained in this study certainly need to be replicated in an independent sample of Russians.
Collapse
Affiliation(s)
- N. G. Kukava
- National Medical Scientific Center for Cardiology, 3rd Cherepkovskaya Str. 15a, Moscow, 121552 , Russia
| | - B. V. Titov
- National Medical Scientific Center for Cardiology, 3rd Cherepkovskaya Str. 15a, Moscow, 121552 , Russia
- Pirogov Russian National Research Medical University, Ostrovitjanova Str. 1, Moscow, 117997, Russia
| | - G. J. Osmak
- National Medical Scientific Center for Cardiology, 3rd Cherepkovskaya Str. 15a, Moscow, 121552 , Russia
- Pirogov Russian National Research Medical University, Ostrovitjanova Str. 1, Moscow, 117997, Russia
| | - N. A. Matveeva
- National Medical Scientific Center for Cardiology, 3rd Cherepkovskaya Str. 15a, Moscow, 121552 , Russia
- Pirogov Russian National Research Medical University, Ostrovitjanova Str. 1, Moscow, 117997, Russia
| | - O. G. Kulakova
- National Medical Scientific Center for Cardiology, 3rd Cherepkovskaya Str. 15a, Moscow, 121552 , Russia
- Pirogov Russian National Research Medical University, Ostrovitjanova Str. 1, Moscow, 117997, Russia
| | - A. V. Favorov
- Oncology Biostatistics and Bioinformatics, Johns Hopkins School of Medicine, Baltimore, MD 21205 , US
| | - R. M. Shakhnovich
- National Medical Scientific Center for Cardiology, 3rd Cherepkovskaya Str. 15a, Moscow, 121552 , Russia
| | - M. Ya. Ruda
- National Medical Scientific Center for Cardiology, 3rd Cherepkovskaya Str. 15a, Moscow, 121552 , Russia
| | - O. O. Favorova
- National Medical Scientific Center for Cardiology, 3rd Cherepkovskaya Str. 15a, Moscow, 121552 , Russia
- Pirogov Russian National Research Medical University, Ostrovitjanova Str. 1, Moscow, 117997, Russia
| |
Collapse
|